GSA CAPITAL PARTNERS LLP

Position in LAB — Standard Biotools Inc.

CIK 1362033 LONDON, X0

Position in LAB

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$325,193

+$264,693 QoQ

Shares Held

353,471

+647.8% QoQ

Ownership

0.091%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $31,522,666 across 48 Medical Devices names. LAB ranks #31 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	44,579	$4,576,925
2	PRCT	PROCEPT BioRobotics Corp	78,677	$1,967,711
3	BSX	Boston Scientific Corp	31,294	$1,963,698
4	PODD	Insulet Corp	7,878	$1,653,119
5	NPCE	NeuroPace Inc	117,672	$1,547,386
6	MASS	908 Devices Inc.	251,028	$1,536,291
7	INFU	InfuSystem Holdings, Inc	162,670	$1,501,444
8	OFIX	Orthofix Medical Inc.	121,226	$1,390,462

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$325,193	353,471	+647.8%	Shares	Sole	2026-05-08
2025-12-31	$60,500	47,266	-84.6%	Shares	Sole	2026-02-06
2025-06-30	$367,784	306,487	-49.6%	Shares	Sole	2025-07-22
2025-03-31	$657,348	608,656	+369.2%	Shares	Sole	2025-05-08
2024-12-31	$227,034	129,734	+27.8%	Shares	Sole	2025-02-07
2021-12-31	$397,856	101,494	+131.2%	Shares	Sole	2022-02-14
2021-09-30	$289,333	43,905	-58.5%	Shares	Sole	2021-11-12
2021-03-31	$478,451	105,852	+152.4%	Shares	Sole	2021-05-10
2020-12-31	$251,664	41,944	-49.4%	Shares	Sole	2021-02-03
2020-09-30	$615,969	82,903	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.